Skip to content
Tuesday, November 17, 2026 · Today’s edition, 6:30 a.m. ETTue, Nov 17 · 6:30 a.m. editionSign inMy Desk 0EditionsSign in
IBRNISharesINDEX

iShares Neuroscience and Healthcare ETF

$33.47-2.15% vs prior close
294152-WK

Price through Nov 16, 2026 · Flows through Nov 13, 2026. Figures use the latest available records, not a live quote. Fund details retrieved Nov 16, 2026. Holdings snapshot retrieved Nov 16, 2026.

The fund will invest at least 80% of its assets in the component securities of its index and in investments that have economic characteristics that are substantially identical to the component securities of its index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents as well as in securities not included in the index, but which BFA believes will help the fund track the index. It is non-diversified.

IBRN price

Source: Market tape, daily closes; price return, distributions not reinvested
Table
DateIBRN close
Aug 17, 2026$39.64
Aug 18, 2026$39.77
Aug 19, 2026$40.67
Aug 20, 2026$39.38
Aug 21, 2026$39.65
Aug 24, 2026$39.53
Aug 25, 2026$40.10
Aug 26, 2026$40.36
Aug 27, 2026$40.30
Aug 28, 2026$39.23
Aug 31, 2026$38.96
Sep 1, 2026$38.94
Sep 2, 2026$39.46
Sep 3, 2026$39.37
Sep 4, 2026$39.06
Sep 8, 2026$38.50
Sep 9, 2026$38.00
Sep 10, 2026$37.33
Sep 11, 2026$37.43
Sep 14, 2026$37.31
Sep 15, 2026$36.20
Sep 16, 2026$36.02
Sep 17, 2026$36.55
Sep 18, 2026$35.19
Sep 21, 2026$35.32
Sep 22, 2026$35.67
Sep 23, 2026$34.11
Sep 24, 2026$33.52
Sep 25, 2026$33.33
Sep 28, 2026$33.47
Sep 29, 2026$33.20
Sep 30, 2026$33.27
Oct 1, 2026$32.87
Oct 2, 2026$32.55
Oct 5, 2026$32.41
Oct 6, 2026$32.04
Oct 7, 2026$31.86
Oct 8, 2026$31.39
Oct 9, 2026$31.75
Oct 12, 2026$31.43
Oct 13, 2026$30.30
Oct 14, 2026$29.96
Oct 15, 2026$30.72
Oct 16, 2026$29.97
Oct 19, 2026$30.79
Oct 20, 2026$31.84
Oct 21, 2026$31.51
Oct 22, 2026$31.75
Oct 23, 2026$31.36
Oct 26, 2026$31.60
Oct 27, 2026$32.24
Oct 28, 2026$32.92
Oct 29, 2026$33.29
Oct 30, 2026$32.84
Nov 2, 2026$32.52
Nov 3, 2026$33.26
Nov 4, 2026$33.97
Nov 5, 2026$32.89
Nov 6, 2026$33.83
Nov 9, 2026$34.87
Nov 10, 2026$34.79
Nov 11, 2026$35.41
Nov 12, 2026$34.34
Nov 13, 2026$34.20
Nov 16, 2026$33.47

Weekly net flows, 3M

Net inflow over the range: +$2M

  • Inflow / above zero
  • Outflow / below zero
Aug 10Aug 17Aug 24Aug 31Sep 7Sep 14Sep 21Sep 28Oct 5Oct 12Oct 19Oct 26Nov 2+$1.8MNov 9Aug 10Aug 24Sep 7Sep 21Oct 5Oct 19+$1.8MNov 9Aug 10Sep 7Oct 5+$1.8MNov 9
Source: Daily creation and redemption records
Show as table
LabelValue ($)
Aug 10$0
Aug 17−$3.6K
Aug 24$366.26
Aug 31$61.2K
Sep 7−$60.2K
Sep 14$0
Sep 21$146.65
Sep 28−$70.07
Oct 5−$304.32
Oct 12$686.95
Oct 19$0
Oct 26$2.6K
Nov 2$0
Nov 9$1.8M
The desk’s read

Money keeps arriving — +$2M of net inflows over the past month, about 20.5% of the fund's asset base, while the price has returned +3.6% so far this year. At 0.47% a year it is not the cheapest way in — IWM has a reported fee of 0.19%.

COMPOSED FROM THE FUND’S OWN DAILY RECORDS · UPDATED WITH EACH REFRESH

$9Massets under management
0.47%expense ratio · $47 per $10,000 a year
+$2Mnet flow, trailing month
4Kavg daily volume, 30 days
67holdings
2022listed August 24, 2022 · beta 1.03
The book at a glance
BIIB-0.7%NBIX-1.2%EWTX-4.9%ALKS-1.1%ARGX-0.9%AXGN-1.0%PTCT-4.0%PRAX-5.4%DNTH-2.5%SRRK+3.1%DYN-2.7%ACAD-0.4%XENE-3.0%BHVN-0.1%SRPT-5.8%LBRX-0.0%TSHA-1.0%ANRO-8.2%RAPP-5.1%IART-2.9%CBLL+1.1%ANNX-8.9%SLDB-5.3%OVID-5.5%CAPR-12.9%NPCE

CELL SIZE IS PORTFOLIO WEIGHT · COLOR IS THE CHANGE IN THE LATEST AVAILABLE SNAPSHOT · TOP 40 POSITIONS

Holdings
#HoldingWeightPriceDay52-wk
1BIIBBIOGEN5.33%$251.65-0.7%
2NBIXNEUROCRINE BIOSCIENCES5.09%$165.31-1.2%
3EWTXEDGEWISE THERAPEUTICS4.96%$43.68-4.9%
4ALKSALKERMES4.75%$46.53-1.1%
5ARGXARGENX SE4.43%$950.95-0.9%
6AXGNAXOGEN4.28%$55.38-1.0%
7PTCTPTC THERAPEUTICS4.29%$60.97-4.0%
8PRAXPRAXIS PRECISION MEDICINES4.30%$310.27-5.4%
9DNTHMAGENTA THERAPEUTICS INC3.98%$89.55-2.5%
10SRRKSCHOLAR ROCK HOLDING3.65%$44.54+3.1%
11DYNDYNE THERAPEUTICS3.27%$16.70-2.7%
12ACADACADIA PHARMACEUTICALS3.03%$18.67-0.4%
13XENEXENON PHARMACEUTICALS3.21%$39.26-3.0%
14BHVNBIOHAVEN2.67%$13.80-0.1%
15SRPTSAREPTA THERAPEUTICS2.39%$15.13-5.8%

The full book, free with one sign-in.

Top 15 positions are open to everyone. Sign in once and every fund’s complete holdings — plus watchlists and flow alerts — unlock across the network.

Sign in to see all 67

Sector weights

  • Healthcare100%
  • Health Care98.18%
  • Information Technology1.08%
  • Cash and/or Derivatives0.74%
Source: Portfolio composition, latest disclosure
Show as table
ItemValue (%)
Healthcare100%
Health Care98.18%
Information Technology1.08%
Cash and/or Derivatives0.74%

Country weights

  • United States73.61%
  • Belgium4.43%
  • Korea (South)3.81%
  • South Korea3.8%
  • Denmark3.45%
  • Sweden3.08%
  • Australia2.61%
  • Japan2.31%
Source: Portfolio composition, latest disclosure
Show as table
ItemValue (%)
United States73.61%
Belgium4.43%
Korea (South)3.81%
South Korea3.8%
Denmark3.45%
Sweden3.08%
Australia2.61%
Japan2.31%
Performance
1 week-3.8%
1 month+11.7%
3 months-14.5%
6 months-3.8%
YTD+3.6%
1 year—
3 years—

PRICE RETURN, DISTRIBUTIONS NOT REINVESTED

Net flows
1 week+$33K
1 month+$2M
3 months+$2M
YTD+$4M
1 year+$4M

CREATION/REDEMPTION DOLLARS, DAILY RECORDS

Monthly net flows

  • Inflow / above zero
  • Outflow / below zero
$0Nov$0Dec$0Jan$0Feb$0Mar$0Apr$0May+$1.7KJul+$2MAug−$59.5KSep+$10.2KOct+$1.8MNovNovDecJanFebMarAprMayJul+$2MAugSepOct+$1.8MNovNovJanMarMay+$2MAug+$1.8MNov
Source: Daily creation/redemption records, trailing twelve months
Show as table
LabelValue ($)
Nov$0
Dec$0
Jan$0
Feb$0
Mar$0
Apr$0
May$0
Jul$1.7K
Aug$2M
Sep−$59.5K
Oct$10.2K
Nov$1.8M
The risk read
32%realized volatility, 30 days (annualized)
27%realized volatility, 1 year
-26.3%deepest fall from a peak, 1 year
-17.7%latest close versus that peak

The top holding is 5.3% of the book; the top ten carry 45%. Spread across 85+ names, it behaves like roughly 36 equally-weighted positions.

VOLATILITY & DRAWDOWN FROM THE DAILY TAPE · CONCENTRATION FROM THE LATEST DISCLOSED BOOK

Options tape
263calls · latest snapshot
526puts · latest snapshot
2.00put/call ratio
2Kshares traded
Most-traded holdings, options premiumBullishBearish
CAPR CAPRICOR THERAPEUTICS$906,988$3M
ARGX ARGENX SE$2M$1M
NBIX NEUROCRINE BIOSCIENCES$965,247$12,455
BIIB BIOGEN$587,112$372,253
SRPT SAREPTA THERAPEUTICS$288,925$480,042

TODAY’S OPTIONS PREMIUM IN THE FUND’S UNDERLYING NAMES

The case against IBRN

Due diligence cuts both ways. These funds sit on the same shelf and beat IBRN on at least one dimension that matters — the fee, the asset base, or where the money is going.

FundFeeAssetsFlow, 1MThe case
SPDW SPDR Portfolio Developed World ex-US ETF0.03%$41.6B+$917M-44bp on fee · 4856× the assets · +$917M in over the monthHead-to-head
SPMD State Street SPDR Portfolio S&P 400 Mid Cap ETF0.03%$18.4B+$199M-44bp on fee · 2140× the assets · +$199M in over the monthHead-to-head
IJH iShares Core S&P Mid-Cap ETF0.05%$123.7B+$109M-42bp on fee · 14424× the assets · +$109M in over the monthHead-to-head
IDEV iShares Core MSCI International Developed Markets ETF0.04%$34B+$587M-43bp on fee · 3965× the assets · +$587M in over the monthHead-to-head
IGSB iShares 1-5 Year Investment Grade Corporate Bond ETF0.04%$23.7B+$422M-43bp on fee · 2768× the assets · +$422M in over the monthHead-to-head
Sign in to save this to The RecordA timestamped copy for the file — documentation, not advice.

Watch & listen: IShares

From the manager behind IBRNAll of Watch & Listen
ETF Dailyfrom Private Wealth Daily

ETF launches, fund research, and market coverage in your inbox every morning. Free.

Free. Every morning. Unsubscribe from any edition in one click.